BMI and mortality in critically ill patients with COVID-19: another brick in the wall of the obesity paradox

Obesity (Silver Spring). 2024 Aug;32(8):1474-1482. doi: 10.1002/oby.24069. Epub 2024 Jun 30.

Abstract

Objective: The objective of this study was to assess the existence of the obesity paradox in patients with COVID-19 admitted to the intensive care unit.

Methods: This was a multicentric retrospective cohort study including individuals aged 18 years or older admitted to the intensive care unit with SARS-CoV-2. Data were obtained from electronic medical records. The primary outcome was in-hospital mortality. Multiple logistic regression and restricted cubic splines analyses were conducted to assess the association between BMI and mortality.

Results: From March 2020 to December 2021, 977 patients met the inclusion criteria, and 868 were included in the analysis. Obesity was identified in 382 patients (44%). Patients with obesity more often underwent prone positioning (42% vs. 28%; p < 0.001), although they used less vasoactive medications (57% vs. 68%; p < 0.001). The overall in-hospital mortality was 48%, with 44% observed in the subgroup of individuals with obesity and 50% in those without obesity (p = 0.06). Patients with BMI < 25 kg/m2 had the highest mortality.

Conclusions: Obesity was not associated with higher mortality rates in critically ill patients with COVID-19. Moreover, patients with BMI < 25 kg/m2 had a higher mortality rate compared with those in higher BMI categories.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Body Mass Index*
  • COVID-19* / complications
  • COVID-19* / mortality
  • Critical Illness / mortality
  • Female
  • Hospital Mortality*
  • Humans
  • Intensive Care Units* / statistics & numerical data
  • Male
  • Middle Aged
  • Obesity Paradox
  • Obesity* / complications
  • Obesity* / mortality
  • Retrospective Studies